Protective effects of necrostatin-1 on glucocorticoid-induced osteoporosis in rats

Journal of Steroid Biochemistry and Molecular Biology

Volumn 144, Issue PB, 2014, Pages 455-462

  Feng, Min ^a   Zhang, Ruirui ^b   Gong, Futai ^c   Yang, Pei ^a   Fan, Lihong ^a   Ni, Jianlong ^a   Bi, Wenchao ^a   Zhang, Yongtao ^a   Wang, Chunsheng ^a   Wang, Kunzheng ^a  

^a XI'AN JIAOTONG UNIVERSITY   (China)

^b Department of ICU 521 Healthy Institutes of North Industries   (China)

^c Xi'an Hospital of Traditional Chinese Medicine   (China)

Author keywords

Caspase 8; Glucocorticoid; Necroptosis; Necrostatin 1; Osteoporosis

Indexed keywords

ALENDRONIC ACID; BIOCHEMICAL MARKER; CALCEIN; CASPASE 8; DEXAMETHASONE; ENZYME INHIBITOR; NECROSTATIN 1; RIP1 PROTEIN; RIP3 PROTEIN; UNCLASSIFIED DRUG; BONE DENSITY CONSERVATION AGENT; CASP8 PROTEIN, RAT; GLUCOCORTICOID; IMIDAZOLE DERIVATIVE; INDOLE DERIVATIVE; NECROSTATIN-1; PROTEIN SERINE THREONINE KINASE; RECEPTOR INTERACTING PROTEIN SERINE THREONINE KINASE; RECEPTOR-INTERACTING PROTEIN 3, RAT; RIP1 PROTEIN, RAT;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE DENSITY; BONE METABOLISM; CONTROLLED STUDY; DRUG INDUCED DISEASE; DUAL ENERGY X RAY ABSORPTIOMETRY; GLUCOCORTICOID INDUCED OSTEOPOROSIS; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; MITOCHONDRION; NECROPTOSIS; NICK END LABELING; NONHUMAN; OSSIFICATION; OSTEOBLAST; OSTEOCYTE; OSTEOLYSIS; OSTEOPOROSIS; RAT; SCANNING ELECTRON MICROSCOPY; TRABECULAR BONE; TRANSMISSION ELECTRON MICROSCOPY; ANIMAL; CHEMICALLY INDUCED; DRUG EFFECTS; FEMUR; METABOLISM; PATHOLOGY; SPRAGUE DAWLEY RAT;

ANIMALS; BONE DENSITY; BONE DENSITY CONSERVATION AGENTS; CASPASE 8; DEXAMETHASONE; FEMUR; GLUCOCORTICOIDS; IMIDAZOLES; INDOLES; MALE; OSTEOCYTES; OSTEOPOROSIS; PROTEIN-SERINE-THREONINE KINASES; RATS, SPRAGUE-DAWLEY; RECEPTOR-INTERACTING PROTEIN SERINE-THREONINE KINASES;

EID: 84907164146     PISSN: 09600760     EISSN: 18791220     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2014.09.005     Document Type: Article

References (51)

1. N.Z. Lu, and J.A. Cidlowski The origin and functions of multiple human glucocorticoid receptor isoforms Ann. N. Y. Acad. Sci. 1024 2004 102 123
2. G. Mazziotti, A. Angeli, J.P. Bilezikian, E. Canalis, and A. Giustina Glucocorticoid-induced osteoporosis: an update Trends Endocrin. Met. 17 2006 144 149
3. R. Rizzoli, J. Adachi, C. Cooper, W. Dere, J.-P. Devogelaer, A. Diez-Perez, J. Kanis, A. Laslop, B. Mitlak, and S. Papapoulos Management of glucocorticoid-induced osteoporosis Calcified Tissue Int. 91 2012 225 243
4. R.S. Weinstein, R.L. Jilka, A.M. Parfitt, and S.C. Manolagas Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids. Potential mechanisms of their deleterious effects on bone J. Clin. Invest. 102 1998 274
5. G. Silvestrini, P. Ballanti, F. Patacchioli, P. Mocetti, R. Di Grezia, B. Martin Wedard, L. Angelucci, and E. Bonucci Evaluation of apoptosis and the glucocorticoid receptor in the cartilage growth plate and metaphyseal bone cells of rats after high-dose treatment with corticosterone Bone 26 2000 33 42
6. N.E. Lane, W. Yao, M. Balooch, R.K. Nalla, G. Balooch, S. Habelitz, J.H. Kinney, and L.F. Bonewald Glucocorticoid-treated mice have localized changes in trabecular bone material properties and osteocyte lacunar size that are not observed in placebo-treated or estrogen-deficient mice J. Bone Miner. Res. 21 2006 466 476
7. T. Van Staa, H. Leufkens, L. Abenhaim, B. Zhang, and C. Cooper Use of oral corticosteroids and risk of fractures J. Bone Miner. Res. 15 2000 993 1000
8. A.W. Eberhardt, A. Yeager-Jones, and H.C. Blair Regional trabecular bone matrix degeneration and osteocyte death in femora of glucocorticoid-treated rabbits Endocrinology 142 2001 1333 1340
9. R.S. Hotchkiss, A. Strasser, J.E. McDunn, and P.E. Swanson Cell death New Engl. J. Med. 361 2009 1570 1583
10. C. Gunther, E. Martini, N. Wittkopf, K. Amann, B. Weigmann, H. Neumann, M.J. Waldner, S.M. Hedrick, S. Tenzer, M.F. Neurath, and C. Becker Caspase-8 regulates TNF-alpha-induced epithelial necroptosis and terminal ileitis Nature 477 2011 335 339
11. Y. Cho, S. Challa, D. Moquin, R. Genga, T.D. Ray, M. Guildford, and F.K.-M. Chan Phosphorylation-driven assembly of the RIP1-RIP3 complex regulates programmed necrosis and virus- induced inflammation Cell 137 2009 1112 1123
12. D. Moquin, and F.K.-M. Chan The molecular regulation of programmed necrotic cell injury Trends Biochem. Sci. 35 2010 434 441
13. D.E. Christofferson, and J. Yuan Necroptosis as an alternative form of programmed cell death Curr. Opin. Cell Biol. 22 2010 263 268
14. J. Hitomi, D.E. Christofferson, A. Ng, J. Yao, A. Degterev, R.J. Xavier, and J. Yuan Identification of a molecular signaling network that regulates a cellular necrotic cell death pathway Cell 135 2008 1311 1323
15. A. Degterev, Z. Huang, M. Boyce, Y. Li, P. Jagtap, N. Mizushima, G.D. Cuny, T.J. Mitchison, M.A. Moskowitz, and J. Yuan Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury Nat. Chem. Biol. 1 2005 112 119
16. D.M. Rosenbaum, A. Degterev, J. David, P.S. Rosenbaum, S. Roth, J.C. Grotta, G.D. Cuny, J. Yuan, and S.I. Savitz Necroptosis, a novel form of caspase- independent cell death, contributes to neuronal damage in a retinal ischemia-reperfusion injury model J. Neurosci. Res. 88 2010 1569 1576
17. C.C. Smith, S.M. Davidson, S.Y. Lim, J.C. Simpkin, J.S. Hothersall, and D.M. Yellon Necrostatin: a potentially novel cardioprotective agent? Cardiovasc. Drug. Ther. 21 2007 227 233
18. S.J. Gilbert, S.K. Singhrao, I.M. Khan, L.G. Gonzalez, B.M. Thomson, D. Burdon, V.C. Duance, and C.W. Archer Enhanced tissue integration during cartilage repair in vitro can be achieved by inhibiting chondrocyte death at the wound edge Tissue Eng. Part A 15 2009 1739 1749
19. F.-S. Wang, J.-Y. Ko, D.-W. Yeh, H.-C. Ke, and H.-L. Wu Modulation of Dickkopf-1 attenuates glucocorticoid induction of osteoblast apoptosis, adipocytic differentiation, and bone mass loss Endocrinology 149 2008 1793 1801
20. S. Lim, S. Davidson, M. Mocanu, D. Yellon, and C. Smith The cardioprotective effect of necrostatin requires the cyclophilin-D component of the mitochondrial permeability transition pore Cardiovasc. Drug. Ther. 21 2007 467 469
21. S. Qiu, D. Rao, S. Palnitkar, and A. Parfitt Age and distance from the surface but not menopause reduce osteocyte density in human cancellous bone Bone 31 2002 313 318
22. H.W. van Essen, P.J. Holzmann, M.A. Blankenstein, P. Lips, and N. Bravenboer Effect of raloxifene treatment on osteocyte apoptosis in postmenopausal women Calcif. Tissue Int. 81 2007 183 190
23. T. Yamamoto, E. Hinoi, H. Fujita, T. Iezaki, Y. Takahata, M. Takamori, and Y. Yoneda The natural polyamines spermidine and spermine prevent bone loss through preferential disruption of osteoclastic activation in ovariectomized mice Br. J. Pharmacol. 166 2012 1084 1096
24. B. Bhargavan, A.K. Gautam, D. Singh, A. Kumar, S. Chaurasia, A.M. Tyagi, D.K. Yadav, J.S. Mishra, A.B. Singh, S. Sanyal, A. Goel, R. Maurya, and N. Chattopadhyay Methoxylated isoflavones, cajanin and isoformononetin, have non-estrogenic bone forming effect via differential mitogen activated protein kinase (MAPK) signaling J. Cell. Biochem. 108 2009 388 399
25. D.W. Dempster, J.E. Compston, M.K. Drezner, F.H. Glorieux, J.A. Kanis, H. Malluche, P.J. Meunier, S.M.R.R. Ott Recker, and A.M. Parfitt Standardized nomenclature, symbols, and units for bone histomorphometry: a 2012 update of the report of the ASBMR Histomorphometry Nomenclature Committee J. Bone Miner. Res. 28 2013 2 17
26. A. Angeli, G. Guglielmi, A. Dovio, G. Capelli, D. de Feo, S. Giannini, R. Giorgino, L. Moro, and A. Giustina High prevalence of asymptomatic vertebral fractures in post-menopausal women receiving chronic glucocorticoid therapy: a cross-sectional outpatient study Bone 39 2006 253 259
27. L.D. Carbonare, M. Arlot, P. Chavassieux, J. Roux, N. Portero, and P. Meunier Comparison of trabecular bone microarchitecture and remodeling in glucocorticoid-induced and postmenopausal osteoporosis J. Bone Miner. Res. 16 2001 97 103
28. R.S. Weinstein Glucocorticoid-induced bone disease New Engl. J. Med. 365 2011 62 70
29. B. Noble, H. Stevens, N. Loveridge, and J. Reeve Identification of apoptotic changes in osteocytes in normal and pathological human bone Bone 20 1997 273 282
30. X. Xia, R. Kar, J. Gluhak-Heinrich, W. Tao, N.E. Lane, L.F. Bonewald, S.K. Biswas, W.K. Lo, and J.X. Jiang Glucocorticoid-induced autophagy in osteocytes J. Bone Miner. Res. 25 2010 2479 2488
31. T.V. Berghe, N. Vanlangenakker, E. Parthoens, W. Deckers, M. Devos, N. Festjens, C. Guerin, U. Brunk, W. Declercq, and P. Vandenabeele Necroptosis, necrosis and secondary necrosis converge on similar cellular disintegration features Cell Death Differ. 17 2010 922 930
32. M. Bras, B. Queenan, and S. Susin Programmed cell death via mitochondria: different modes of dying Biochemistry (Moscow) 70 2005 231 239
33. N.B. Watts Clinical utility of biochemical markers of bone remodeling Clin. Chem. 45 1999 1359 1368
34. B. Bouvard, M. Audran, E. Legrand, and D. Chappard Ultrastructural characteristics of glucocorticoid-induced osteoporosis Osteoporos. Int. 20 2009 1089 1092
35. S. Minisola, R. Del Fiacco, S. Piemonte, M. Iorio, M. Mascia, F. Fidanza, C. Cipriani, I. Raso, M. Porfiri, and C. Francucci Biochemical markers in glucocorticoid- induced osteoporosis J. Endocrinol. Invest. 31 2008 28 32
36. L. Dalle Carbonare, F. Bertoldo, M. Valenti, S. Zenari, M. Zanatta, S. Sella, S. Giannini, and V.L. Cascio Histomorphometric analysis of glucocorticoid-induced osteoporosis Micron 36 2005 645 652
37. K.G. Saag, J.R. Zanchetta, J.P. Devogelaer, R.A. Adler, R. Eastell, K. See, J.H. Krege, K. Krohn, and M.R. Warner Effects of teriparatide versus alendronate for treating glucocorticoid-induced osteoporosis: thirty-six-month results of a randomized, double-blind, controlled trial Arthritis Rheum. 60 2009 3346 3355
38. P.M. Chavassieux, M.E. Arlot, J.P. Roux, N. Portero, A. Daifotis, A.J. Yates, N.A. Hamdy, M.P. Malice, D. Freedholm, and P.J. Meunier Effects of alendronate on bone quality and remodeling in glucocorticoid-induced osteoporosis: a histomorphometric analysis of transiliac biopsies J. Bone Miner. Res. 15 2000 754 762
39. W. Whitehouse The quantitative morphology of anisotropic trabecular bone J. Microsc. 101 1974 153 168
40. I.H. Parkinson, and N.L. Fazzalari Interrelationships between structural parameters of cancellous bone reveal accelerated structural change at low bone volume J.Bone Miner. Res. 18 2003 2200 2205
41. B.R. McCreadie, S.J. Hollister, M.B. Schaffler, and S.A. Goldstein Osteocyte lacuna size and shape in women with and without osteoporotic fracture J. Biomech. 37 2004 563 572
42. K.B. Emerton, B. Hu, A.A. Woo, A. Sinofsky, C. Hernandez, R.J. Majeska, K.J. Jepsen, and M.B. Schaffler Osteocyte apoptosis and control of bone resorption following ovariectomy in mice Bone 46 2010 577 583
43. P. Vandenabeele, W. Declercq, F. Van Herreweghe, and T. Vanden Berghe The role of the kinases RIP1 and RIP3 in TNF-induced necrosis Sci. Signal. 3 2010 re4
44. R. Caltabiano, R. Leonardi, G. Musumeci, G. Bartoloni, M.C. Rusu, L.E. Almeida, and C. Loreto Apoptosis in temporomandibular joint disc with internal derangement involves mitochondrial- dependent pathways. An in vivo study Acta Odontol. Scand. 71 2013 577 583
45. L. Galluzzi, N. Joza, E. Tasdemir, M. Maiuri, M. Hengartner, J. Abrams, N. Tavernarakis, J. Penninger, F. Madeo, and G. Kroemer No death without life: vital functions of apoptotic effectors Cell Death Differ. 15 2008 1113 1123
46. M.F. Dallman, S.F. Akana, N.C. Pecoraro, J.P. Warne, S.E. la Fleur, and M.T. Foster Glucocorticoids, the etiology of obesity and the metabolic syndrome Curr. Alzheimer Res. 4 2007 199 204
47. J.M. Eason, S.L. Dodd, S.K. Powers, and A.D. Martin Detrimental effects of short-term glucocorticoid use on the rat diaphragm Phys. Ther. 80 2000 160 167
48. J. Won Jahng, N.Y. Kim, V. Ryu, S.B. Yoo, B.-T. Kim, D.-W. Kang, and J.-H. Lee Dexamethasone reduces food intake, weight gain and the hypothalamic 5-HT concentration and increases plasma leptin in rats Eur. J. Pharmacol. 581 2008 64 70
49. E. Löfberg, A. Gutierrez, J. Wernerman, B. Anderstam, W. Mitch, S. Price, J. Bergström, and A. Alvestrand Effects of high doses of glucocorticoids on free amino acids, ribosomes and protein turnover in human muscle Eur. J. Clin. Invest. 32 2002 345 353
50. H. Masaki, and T. Miki Biochemical markers of bone in steroid (glucocorticoid)-induced osteoporosis (GIOP) Clin. Calcium 16 2006 1823 1832
51. M. Yamaguchi, R. Hamamoto, S. Uchiyama, and K. Ishiyama Effects of flavonoid on calcium content in femoral tissue culture and parathyroid hormone- stimulated osteoclastogenesis in bone marrow culture in vitro Mol. Cell. Biochem. 303 2007 83 88